GSK’s Jemperli has claimed an edge over its main rival in the endometrial cancer therapy market after showing improved overall survival in a broad patient population in th
Clinical research continues to struggle with a lack of representation within trial populations, and gender diversity in clinical trials remains a critical issue.
As all eyes are on a landmark Supreme Court hearing on how patients in the US can access abortion pill mifepristone next month, a study has found that it is safe and effec
The disparity in access to healthcare between women and men around the world is often talked about, but has never been given a dollar value – until now.
The Supreme Court of the US has said it will consider a lower court ruling that would restrict access to the abortion pill mifepristone and is considered to be tied to the